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Decreased drug accumulation is a common cause of antibiotic resistance in microorganisms. 
However, there are few reliable general techniques capable of quantifying drug uptake through 
bacterial membranes. We present a semi-quantitative optofluidic assay for studying the uptake of 
autofluorescent drug molecules in single liposomes. We studied the effect of the Escherichia coli 
outer membrane channel OmpF on the accumulation of the fluoroquinolone antibiotic, norfloxacin, 
in proteoliposomes. Measurements were performed at pH 5 and pH 7, corresponding to two 
different charge states of norfloxacin that bacteria are likely to encounter in the human 
gastrointestinal tract. The optofluidic assay estimates a flux of about 10 norfloxacin molecules per 
second per OmpF trimer in the presence of a 1 mM concentration gradient of norfloxacin. We also 
performed single channel electrophysiology measurements and found that the application of 
transmembrane voltages causes an electric field driven uptake in addition to concentration driven 
diffusion. We use our results to propose a physical mechanism for the pH mediated change in 
bacterial susceptibility to fluoroquinolone antibiotics. 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
Antimicrobial resistance is a daunting challenge, threatening to undermine the very fabric of 
modern medicine today1-4. The inexorable emergence of resistant organisms, coupled with a 
decline in the discovery of new antimicrobials, has led to a global public health crisis. The recent 
breakthrough discovery of a new antibiotic, teixobactin5, is extremely good news. However, its 
relative inactivity against Gram-negative pathogens shows that the battle against antimicrobial 
resistance will be extremely challenging.  
Gram-negative bacteria have a hydrophobic double-membrane cell wall that presents a barrier 
for hydrophilic molecules trying to enter the cell. The outer membrane (OM) is even more 
hydrophobic than a typical phospholipid membrane due to the presence of lipopolysaccharides 
(LPS), whose strong lateral interactions inhibit the passage of a variety of compounds through 
the OM6. Translocation across the OM is thus mainly governed by the presence of outer 
membrane protein “porins” that form water-filled channels allowing the diffusion of compounds 
through the OM.  
 
Consequently, the down-regulation of these porins enables bacteria to escape the deleterious 
effects of antibiotics6-9. For example, a reduction in the expression of Outer membrane protein F 
(OmpF), a major porin found in Escherichia coli, has been associated with a decrease in the 
accumulation of fluoroquinolone antibiotics; this eventually gives rise to drug resistance7,10-12. 
Furthermore, antibiotic therapy results in a switch in porin expression from OmpF to the narrower 
OmpC; this is thought to be due to the high osmolarity conditions existing in patients under drug 
treatment7. This leads to a significant decrease in antibiotic accumulation within the cell, and 
hence a decrease in antibiotic susceptibility7. It is thus clear that understanding antibiotic 
accumulation in cells is crucial, and methods to better quantify antibiotic permeation are urgently 
required13. 
 
Fluoroquinolones are broad-spectrum antibiotics that inhibit bacterial type II topoisomerases. 
These topoisomerases are essential enzymes, involved in key cellular processes such as DNA 
replication14. Since their targets are intracellular, fluoroquinolones must pass through the outer 
and inner bacterial membrane to be effective10. The OM thus presents the initial diffusion barrier 
for drug uptake, and the accumulation of fluoroquinolone molecules in the periplasm ultimately 
determines their flux into the cytoplasm. Changes in bacterial susceptibility to fluoroquinolones 
due to changes in pH have been reported previously15,16. An increase in external pH from acidic 
to basic was shown to correspond to a reduction in the minimum inhibitory concentration (MIC) of 
norfloxacin17. Further, it was proposed that this pH mediated change in susceptibility is related to 
changes in the uptake of fluoroquinolones due to alterations of the electric charge of the antibiotic 
molecule18,19; norfloxacin, for example, is positively charged at pH 5 and neutral (zwitterionic, but 
a significant proportion are also uncharged) at pH 718,19. It thus seems reasonable to assume that 
the fluoroquinolone susceptibility of bacteria in response to pH changes is a complicated process, 
which might involve both changes in porin expression20 and changes in drug transport through 
porins in the OM as well as through the phospholipid inner membrane. 
 
At acidic pH values, fluoroquinolone molecules carry charge18 and thus transport across the OM 
should be strongly influenced by even relatively small potentials across the OM. Donnan 
potentials are known to exist across the OM due to the presence of anchored, anionic membrane-
derived oligosaccharides (MDOs) in the E. coli periplasm21,22. The magnitude of these potentials 
depends strongly on the ionic concentration of the surrounding medium. At physiological ion 
concentrations, the Donnan potential is of the order of 20-30 mV, but variations of 5-100 mV have 
been reported by changing external cation concentrations21. One would expect such changes to 
have a significant effect on the transport of charged molecules through OM porins. 
 
For autofluorescent antibiotics like quinolones, the determination of antibiotic uptake via a cell 
ensemble recording has previously been suggested. However, the technique suffers from 
difficulties in distinguishing between antibiotic molecules that were accumulated inside versus 
those bound to the cell membrane23. More recently, fluorescence based single cell imaging 
enabled the comparison of fleroxacin uptake in resistant versus susceptible bacteria24. However, 
barring these few exceptions, a quantitative analysis of fluoroquinolone transport through porins 
and lipids has proven technologically challenging.  
 
In this study we describe an optofluidic assay that measures the permeability of antibiotics through 
porins exclusively in a proteoliposome system. OmpF porins are reconstituted into giant 
unilamellar vesicles and norfloxacin uptake into these proteoliposomes is tracked directly in a 
label-free manner using the UV autofluorescence of the drug. Patching the proteoliposomes 
reveals an estimate of the porin density, and combining the two measurements enables the 
calculation of norfloxacin translocation rates through OmpF channels in the proteoliposomes. 
Furthermore, proteoliposomes are cell-free systems, and thus active or passive uptake processes 
can be independently examined in highly controlled environments. We compare our 
measurements with single channel electrophysiology, and explore the combined effect of pH and 
transmembrane voltage on norfloxacin transport through OmpF.  
 
Results 
 
Optofluidic Permeability Assay 
 
Figure 1. Optofluidic permeability assay shows the rapid uptake of norfloxacin in OmpF embedded proteoliposomes. Comparison 
of the uptake measurements in liposomes and proteoliposomes at pH 5 (a and b) and pH 7 (d and e). Each point references an 
uptake measurement at the single vesicle level, the grey points being t = 0 and the green (pH 5) and red (pH 7) being the final 
detection point t = tf. On average it took individual vesicles about 7.5 s to move from the initial to the final detection point. In the 
absence of porins (a,d), there is no shift in I values observed at the later time point at either pH. The presence of porins (b,e) 
leads to a marked downward shift in I for the majority of the proteoliposomes at the later detection point, both at pH 5 and pH 
7. The downward shift in I corresponds to an increase in the norfloxacin autofluorescence intensity within the proteoliposome 
(Iin), and is thus a direct measure of norfloxacin uptake. Scatter plots of other porin experiments are presented in the 
Supplementary Information. The histograms (c,f) are a record of permeability coefficients (P) measured for individual porin-
embedded proteoliposomes, and summarise the data from 3 separate experiments at each pH. Histograms from the control 
measurements with liposomes (no porins) are overlaid to show the shift in P due to the presence of porins in the membrane. Total 
liposomes/proteoliposomes detected were N = 268 (pH 5, with porins), N = 74 (pH 5, no porins), N = 420 (pH 7, with porins) and N 
= 74 (pH 7, no porins). 
In the optofluidic permeability assay, OmpF embedded proteoliposomes (see Methods) are 
exposed to norfloxacin by controlled mixing in a T junction microfluidic chip. The vesicles 
(liposomes/proteoliposomes) are imaged under UV irradiation at two points, first immediately post 
mixing with the drug and then again after time t, a short distance further downstream. A 
comparison of the drug UV autofluorescence intensities within the vesicles at both points enables 
the direct visualisation of drug uptake and the calculation of the permeability coefficient (P) and 
flux (J) of the drug through the vesicle membrane. This assay also allows the comparison of 
norfloxacin flux values through OmpF at different pH conditions in the absence of an applied 
transmembrane voltage. 
The results of the optofluidic permeability assay are summarised in Figure 1 – more results can 
be viewed in the Supplementary Information Figure S1. The graphs (Figures 1 a,b,d,e) show a 
normalised intensity difference (I = {(Iout – Iin)/Iout}) between the background autofluorescence 
intensity (Iout) and the autofluorescence intensity inside the vesicle (Iin), versus vesicle radius (R). 
Each point represents a single vesicle measurement. The grey squares represent vesicles at the 
initial viewpoint immediately post mixing with the norfloxacin (which for convenience we set to t = 
0). The green triangles (pH 5) and red circles (pH 7) represent vesicles once they have travelled 
along the channel to the next detection position. The Permeability Coefficient (P) is given by25: 
𝑃 =  − (
𝑅
3𝑡
) × ln (∆𝐼(𝑡) − ∆𝐼(0) + 1) 
where t is the time taken for the vesicle to move from the initial detection point to the final detection 
point (on average this was about 7.5 s).The norfloxacin concentration present in the channel after 
mixing is about 1 mM; at t = 0, there is no norfloxacin inside the vesicles, whereas outside the 
vesicles the concentration is 1 mM. 
The experiments were performed at pH 5 and pH 7. In both cases the presence of OmpF causes 
a marked change in I indicating the rapid accumulation of the drug inside the proteoliposomes.  
Control measurements in the absence of OmpF revealed a substantially slower uptake, indicating 
that OmpF porins significantly enhance the permeability of the membranes to norfloxacin. We can 
calculate the contributions to the flux from the porins and lipids separately; details are given in the 
Supplementary Information. In contrast to permeation in the absence of OmpF25, the presence of 
the porins leads to similar permeability coefficients at both pH 5 and pH 7. The relative pH 
independence suggests that the charge of the molecule does not play a significant role in 
influencing its transport through the porin in the absence of a transmembrane potential. 
The spread in the permeability coefficient histograms (Figure 1 c,f) is caused by the inevitable 
variability of OmpF insertions into individual vesicles prepared for the optofluidics experiments. 
This can be seen in the scatter plots as well – it is clear that, at both pH conditions, a handful of 
vesicles do not show significant transport. It is known, however, that electroformation produces 
some multilamellar vesicles26, and in these the porins cannot insert across all membranes; this 
accounts for the few negative observations.  
Norfloxacin Flux Calculation in the Proteoliposomes 
To obtain an estimate of the flux per porin from the optofluidics assay, vesicles incubated with 
OmpF were patched and characterised electrically using a Port-a-Patch system (Nanion 
Technologies GmbH, Germany) (Supplementary Figure S2). Since the patched area is well-
known (patch diameter = 1 m) and the number of porin insertions counted (using the ionic current 
characteristics, details in Methods), this calibration measurement established a [porin]:[lipid 
surface area] ratio for the vesicles. Our results yield an estimate of ~2000 porins per m2 for the 
proteoliposomes used in the optofluidics assay. It is interesting to compare this result to the 
estimated number of general diffusion porins found in a typical bacterial cell; these porins are 
found in excess of 105 copies per cell6. This translates into an approximately 6× higher [porin]:[lipid 
surface area] ratio than for our experiments. 
The flux of norfloxacin through the vesicle membrane is given by J = P×4R2×c. Combining this 
with the Port-a-Patch measurements, we can calculate the flux per porin on a single 
proteoliposome basis (full details of the calculation are provided in the Supplementary 
Information). An average over all the proteoliposomes detected gives a norfloxacin flux value per 
porin of 10 ± 7 molecules/s (N=420) at pH 7 and 14 ± 9 molecules/s (N=268) at pH 5 (errors are 
Standard Deviations). The errors are a direct consequence of the variability in OmpF insertion, 
as seen in the Supplementary Information Figure S2. If we include a correction (details in 
Supplementary Information) to account for the contribution of flux across the pure lipids25, the 
change in the final result is negligible - at pH 7 the flux per porin is marginally reduced to 9 ± 7 
molecules/s; at pH 5 there is no change.  
Antibiotic interaction with OmpF using Single channel electrophysiology 
In this assay, electrophysiology was used to study the interaction of norfloxacin with OmpF 
channels reconstituted in planar lipid bilayers. Traditionally, a lipid bilayer is formed across an 
aperture in a Teflon film that separates two reservoirs in a cuvette. The reservoirs are filled with 
an electrolyte solution and a potential difference is applied across the lipid membrane via 
electrodes in the reservoirs. Porins are reconstituted in the lipid bilayer and their conductance 
properties studied by measuring the ionic current flowing through the membrane. The addition of 
antibiotics leads to blockages in the ionic current, since the antibiotic molecules displace ions 
flowing through the porin. A detailed description of the technique is provided in the Methods 
section. 
We varied the transmembrane voltages (25 mV and 50 mV) to determine whether the charge on 
the norfloxacin molecule at pH 5 influenced its transport through the channel under an applied 
electric field comparable to the OM potentials in natural systems. In the absence of antibiotics, 
fluctuations in the ionic current through a single OmpF channel were negligible, both at pH 7 and 
pH 5 (Figures 2a and 2c). The addition of 250 µM norfloxacin to the extracellular (cis) side of the 
protein at pH 7 led to well resolved blockages of ionic current as shown in Figure 2b. 
 
 Figure 2. Ionic current traces of a single trimeric OmpF porin: (a) in the absence of antibiotics at pH 7, (b) with 250 M norfloxacin 
cis side at pH 7, (c) in the absence of antibiotics at pH 5 and (d) with 250 M norfloxacin cis side at pH 5. Electrolyte conditions: 1 
M KCl, 5 mM acetate (pH 5) or 5 mM PO4 (pH 7). The applied voltage was -25 mV. The dotted lines specify the ionic current levels 
through single monomers of the OmpF trimer. The addition of norfloxacin at pH 7 (b) leads to well resolved blockages of the ionic 
current through a monomer, whereas at pH 5 (d) the antibiotic molecules lead to flickering in the ionic current through a monomer 
– full blockages are not always observed. This is due to the low residence time of the antibiotic in the channel at pH 5, as discussed 
in the text.   
At pH 5, the addition of 250 M norfloxacin gave rise to partial unresolved flickering in the ionic 
current (Figure 2d); the ionic current through a monomer was not completely blocked due to the 
presence of the antibiotic. This was due to the low residence times of the norfloxacin molecules 
in the channel at pH 5, as discussed below.  
The kinetic rate constants (association and dissociation rates) characterising the interaction of 
norfloxacin molecules with the OmpF channel were calculated as described previously27; these 
are quantified in Table 1. Interestingly, the dissociation rate of the antibiotic varied by an order of 
magnitude at the different pH conditions. At pH 7 the residence time in the channel was about 
900 µs (-25 mV experiments). However at pH 5, when the molecule is positively charged, this 
reduced to 40 µs (Table 1). This imbalance in the pH 7 and pH 5 residence times was observed 
at the higher transmembrane voltage of -50 mV as well (650 s and 40 s respectively). An 
obvious explanation suggests that the positive charge on the norfloxacin molecules at pH 5 results 
in them being driven through the porin under an applied transmembrane voltage. At pH 7 the 
overall charge on the molecule is neutral and thus the transmembrane voltage is less important; 
free diffusion is the primary driving agent. However, there might still be some small voltage 
dependent effects since a significant proportion of the molecules are zwitterionic at pH 7 – this 
requires further investigation. 
This interpretation seems validated by the flux values. The flux (J molecules/s) of norfloxacin 
through the channel was calculated based on a flux model valid for both symmetric and 
asymmetric transport through a channel27-30. When a transmembrane voltage of -25 mV was 
applied across the bilayer, the flux was found to be slightly higher at pH 5 (~ 2 molecules/s) than 
at pH 7 (~ 1 molecule/s). When the transmembrane voltage was increased to -50 mV, the 
norfloxacin flux value at pH 5 increased to 5 ± 1 molecules/s while the flux at pH 7 remained 
unchanged (1 molecule/s). This suggests that the positive charge on the norfloxacin molecule at 
pH 5 does influence its transport through the porin under an applied transmembrane voltage. Note 
that the flux was calculated using c = 1 mM, to compare with the optofluidic permeability assay 
results described above. This is justified since it was observed that the number of antibiotic events 
in the ionic current recordings increased linearly with an increasing concentration of the antibiotic, 
and hence the rate constants measured with a concentration difference of 250 M were equally 
applicable at a concentration difference of 1 mM. 
Discussion 
In this study, we used a label-free optofluidic permeability assay alongside single channel 
electrophysiology to explore the pH and voltage dependence of norfloxacin transport through 
OmpF porins. The optofluidic assay directly proves that the uptake of norfloxacin is enhanced by 
OmpF reconstituted in the proteoliposomes.  
An interesting pattern emerges: in the absence of any transmembrane potential, the optofluidics 
assay shows that the flux per porin is essentially the same (within error) at both pH 5 and pH 7. 
However, as the transmembrane voltage is increased (electrophysiology), the flux at pH 5 starts 
to increase over the flux at pH 7. At a transmembrane voltage close to typical physiological OM 
Donnan potentials21 of -25 mV, the flux at pH 5 is twice as large as the flux at pH 7. On increasing 
the transmembrane voltage to -50 mV, the flux at pH 5 increases to five times that at pH 7. This 
confirms that the positive charge on norfloxacin at pH 5 contributes significantly to its transport 
across porins in the presence of transmembrane voltages. 
It has been reported that a change in the pH from acidic to basic reduced the minimum inhibitory 
concentration (MIC) of norfloxacin17; furthermore, the antibiotic showed maximum cytoplasmic 
accumulation at pH 7.518. This agrees well with the data obtained in our study. As mentioned 
above, our experiments suggest that norfloxacin will accumulate in the periplasm (across the 
porin) of an E. coli bacterium at a 2× faster rate at pH 5 compared to pH 7. However, the drug 
molecules now encounter the phospholipid inner membrane (IM). Our previous work showed that 
the direct diffusion of norfloxacin through a pure vesicle lipid bilayer is more effective (by a factor 
of approximately 6×) at pH 7 than at pH 525. Furthermore, the periplasmic pH is expected to be 
the same as the external pH31. Considering the relative rates of norfloxacin transport across the 
two membranes at pH 5 and pH 7 thus explains the higher cytoplasmic accumulation at 
neutral/slightly basic pH values17,18. This suggests that diffusion through the inner membrane 
might present the rate limiting step. However, it should also be noted that medium acidification 
leads to the preferential expression of the narrower OmpC porins over OmpF20 in E. coli, which 
might further reduce norfloxacin accumulation at acidic pH values.  
Our analysis of norfloxacin transport through porins and lipids has thus clarified some of the 
mechanisms by which drug transport is affected under changing external conditions. The 
optofluidics assay also presents a direct visualisation of norfloxacin uptake across a 
proteoliposome membrane in a microfluidic, label-free system, not previously possible. The 
results unambiguously confirm the importance of these porins in facilitating the transport of 
fluoroquinolone antibiotics across the OM. In addition, our optofluidic technique enables the 
measurement of contributions to diffusion from pure lipids25 and through porins, which cannot be 
done in a quantitative manner using the established liposome swelling assays7,32,33. Furthermore, 
our microfluidic based approach has the potential to explore a wide range of porins. 
Proteoliposomes could be devised containing a combination of passive diffusion porins and active 
transporters, to study competition between these processes. New vesicle preparation 
techniques34 have shown considerable promise for integration into lab-on-a-chip devices, which 
should translate into better control over porin insertions and proteoliposome modification. A 
combination of traditional and advanced single vesicle techniques can thus be used to investigate 
a variety of drug transport phenomena, an urgent need in medicine today.  
 
Methods 
Optofluidic Permeability Assay 
 
Figure 3. Schematic of the optofluidic permeability assay. Control experiments (no porin) are represented in a) and proteoliposome 
experiments (containing OmpF) in b). Vesicles (liposomes/proteoliposomes) are mixed with norfloxacin in a T junction microfluidic 
chip by applying suction at the outlet reservoir with a syringe pump; norfloxacin autofluorescence is stimulated with a UV 
epifluorescence microscope. The vesicles are detected at an initial time ti immediately post mixing and at a later time tf, a distance 
of 7.4 mm further downstream. Vesicles took, on average, about 7.5 s to travel the intervening distance. Both time points are 
observed in the same field of view. Detection of the autofluorescence intensities within the vesicles at both points enables the 
calculation of the drug permeability coefficient for each vesicle. 
The optofluidic permeability assay builds on our previous work studying the Permeability 
Coefficient of norfloxacin across lipid membranes25. It was designed to explore properties of porin 
mediated transport not accessible to electrophysiology and other traditional techniques. It enables 
the study of drug transport through porins without the application of a transmembrane voltage. 
Furthermore, even though electrophysiology has been the method of choice for characterising 
antibiotic-porin interactions at the single molecule level35-38, it suffers from an inability to 
distinguish molecules that translocate through the porin from molecules that simply bind 
transiently27. The optofluidic permeability assay visualises drug transport directly, by observing 
the drug molecules themselves via their autofluorescence; it is thus label-free. Liposome swelling 
assays32,33 were previously used as an alternative to electrophysiology. However, these measure 
antibiotic flux relative to the flux of a permeable sugar (generally arabinose) and hence cannot 
measure drug permeability directly. Furthermore, the diffusion of charged compounds in these 
assays is influenced by the build-up of Donnan potentials inside the liposomes, which can lead to 
unexpected osmotic behaviour32. Our assay overcomes many of these intrinsic limitations and 
provides a new technique for studies of drug transport with porins. 
 
As described in Figure 3, the optofluidic permeability assay involves a T junction microfluidic chip 
where the vesicles (liposomes/proteoliposomes) and the drug molecules are mixed in a channel 
(via the application of suction at the outlet). The T junction geometry of the chip leads to an equal 
mixing of vesicle and drug solutions. The inlet norfloxacin concentration is 2 mM (prepared in the 
same buffer solution as the vesicles) and hence the vesicles are exposed to a final norfloxacin 
concentration of 1 mM. The vesicles are imaged immediately post mixing with the norfloxacin and 
at a distance 7.4 mm further along the channel; the chip was designed such that both points were 
observed in the same field of view (Figure 3). The chip design was based on preliminary 
experiments which showed that a distance of about 7-8 mm between the two points was optimal 
for the detection of proteoliposomes showing increased uptake of the drug.   
The norfloxacin molecules were tracked by stimulating their autofluorescence in the UV25. We 
performed all the optofluidics experiments described in this paper on a commercial Olympus IX73 
microscope, using a DAPI filter set (Chroma) and a Mercury arc lamp (Prior Lumen 200). A 60× 
air objective was used (Olympus LUCPlanFLN, NA 0.70). Images were recorded using a scientific 
CMOS camera (optiMOS, QImaging) which enabled recording at 100 fps (10 ms exposure, bin 
4). The microfluidic flows were controlled using a neMESYS syringe pump with a 250 l Duran 
Borosilicate glass syringe (ILS, Germany) connected to the outlet. At the beginning of the 
experiments, a flow of 30-40 l/hr was applied until the autofluorescence intensity in the 
microfluidic channel reached its peak, ensuring an appropriate drug concentration in the channel. 
Once this level was reached, the flow was slowed to 3 l/hr enabling the detection of individual 
vesicles for multiple frames as desired25.      
The images were recorded using Micromanager 1.439 and analysed in MATLAB (scripts available 
on request) to obtain information about the autofluorescence intensities within the vesicles, in 
addition to the background intensity, vesicle shape and velocity25. Upchurch 1520 G tubing (inner 
diameter 0.03 inch) was used to connect the outlet of the chip to the syringe. Full details of the 
mathematical model and permeability coefficient calculations can be found in the earlier paper25. 
Calculations of the flux are presented in the Supplementary Information document. 
Microfluidic Chip Fabrication 
The microfabrication of the fluidic chip relies on photolithography and replica molding. For the 
fabrication of the mold, a Silicon substrate was covered with a thin layer of adhesion promoter 
(Omnicoat, Microchem, spin coating: 2,000 r.p.m., 30 sec). A layer of SU-8 2025 (Microchem) 
was then deposited (2,000 r.p.m., 30 s), pre-baked (2 min at 65 °C, 5 min at 95 °C) and selectively 
exposed to ultraviolet light (12 s, 365-405 nm, 20 mWcm-2) through a bespoke pellicle mask 
(Photodata Ltd, CAD file available on request). The sample was post-baked (1 min at 65 °C, 3 
min at 95 °C), developed for 3 min, dried with a gentle stream of Nitrogen and hard baked for 5 
min at 95 °C. 
Sylgard 184 polydimethylsiloxane (PDMS) was used to create a negative replica from the Silicon 
mold using standard soft lithography techniques40 with an elastomer:curing agent ratio of 9:1 (Dow 
Corning). The PDMS mixture was poured onto the Silicon mold and baked at 60 °C for 55 minutes. 
The PDMS chip was then peeled off the mold and inlet/outlet columns created using a 1.5 mm 
biopsy punch (Miltex). The chip was plasma bonded to a glass coverslip (Type I, Assistent, 
Germany) using an air plasma (10 W, 25 sccm, 10 s exposure, Diener, Royal Oak, MI). Post 
plasma bonding, the chip was left in an oven at 60 °C for 5-10 minutes to enhance the adhesion 
of PDMS to glass.    
Vesicle formation and OmpF incubation 
Giant Unilamellar Vesicles (GUVs) of 1,2-diphytanoyl-sn-glycero-3-phosphocholine (DPhPC) 
lipids (Avanti Polar Lipids) were prepared via electroformation using a Nanion Vesicle Prep Pro 
(Nanion Technologies GmbH, Germany) setup as described previously25. The GUVs were 
prepared in 200 mM Sucrose with 5 mM Phosphate Buffer (pH 7) or 5 mM Acetic Acid (pH 5).  
The OmpF incubation followed previously established protocols41. Purified stock OmpF (5.5 
mg/ml) in a detergent, a 1% solution of n-Octylpolyoxyethylene (octyl-POE, Bachem) prepared in 
Milipore water, was diluted 1:1 in the same detergent and vortexed; 1 l of this freshly diluted 
OmpF solution was added to 199 l of the vesicle stock solution and incubated at room 
temperature for an hour. Biobeads® SM-2 (Bio-Rad) were added to remove the detergent and the 
mixture was incubated at room temperature for 45-60 minutes followed by storage at 4 °C 
overnight. The next day, the OmpF embedded proteoliposome solution was separated from the 
Biobeads with a pipette and the sample used directly in experiments. For the control (liposome) 
experiments, 1 l of 1% octyl-POE (instead of the OmpF solution) was added to 199 l of the 
vesicles; the rest of the incubation protocol remained unchanged.  
Single OmpF porin ionic current measurements in a solvent-free lipid bilayer 
Reconstitution experiments and noise analyses were performed as described in detail 
previously42. The Montal and Mueller technique43 was used to form a phospholipid bilayer using 
DPhPC (Avanti polar lipids). A Teflon film comprising an aperture of approximately 30-60 µm in 
diameter was placed between the two chambers of a cuvette. The aperture was pre-painted with 
1% hexadecane in hexane for stable bilayer formation. 1 M KCl in 5 mM potassium acetate (pH 
5) or 5 mM phosphate (pH 7) was used as the electrolyte solution and added to both sides of the 
chamber. Ionic currents were detected using standard silver-silver chloride electrodes from WPI 
(World Precision Instruments) that were inserted in both sides of the cuvette. Single channel 
measurements were performed by adding the protein to the cis side of the chamber (the side 
connected to the ground electrode). Spontaneous channel insertion was typically obtained while 
stirring the solution in the cuvette under an applied transmembrane voltage. After a successful 
single channel reconstitution, the cis side of the chamber was carefully perfused to remove any 
remaining porins, thus preventing further channel insertions. Conductance measurements were 
performed using an Axopatch 200B amplifier (Molecular Devices) in voltage clamp mode. Signals 
were filtered by an on-board low pass Bessel filter at 10 kHz with a sampling frequency of 50 kHz. 
Amplitude, probability and noise analyses were performed using OriginPro 8 (OriginLab) and 
Clampfit software (Molecular Devices). Single channel analysis was used to determine the 
antibiotic binding kinetics. In a single channel measurement, the quantities measured were the 
duration of blocked levels/residence times (τc) and the frequency of blockage events (ν). The 
association rate constant kon was derived using the number of blockage events, kon = ν/3[c], where 
[c] is the concentration of the antibiotic. The dissociation rate constant (koff) was determined by 
averaging the 1/τc values recorded over the entire concentration range38. 
 
Port-a-Patch  
Planar lipid bilayers were obtained from GUVs prepared using the same electroformation protocol 
described earlier. Purified stock OmpF (5.5 mg/ml) porins in 1% octyl-POE were diluted in the 
detergent and reconstituted into GUVs by incubating the porins as described previously; however, 
the final porin concentrations used in the Port-a-Patch calibration experiments were a factor of 
500×, 250× and 100× more dilute than the final concentration used in the optofluidics assay to 
enable the counting of single porin insertions in the ionic current traces. After incubation, the 
detergent was removed using Biobeads® SM-2 (Bio-Rad) as described previously. The Biobeads 
were discarded after centrifugation and the protein containing GUVs (proteoliposomes) used 
immediately. 
For the formation of a planar lipid bilayer containing the proteins, 5 µl of the proteoliposome 
solution was pipetted into 5 µl of the electrolyte solution (200 mM KCl, 5 mM acetic acid for pH 5 
or 5 mM phosphate for pH 7). The resulting solution was placed on a microstructured glass chip 
(grounded side) containing an aperture approximately 1 µm in diameter. The vesicles burst once 
they touch the glass surface of the chip thus forming a planar lipid bilayer; additional suction was 
applied to patch GUVs across the aperture. Ionic current measurements were performed using 
the same equipment and software as for the black lipid membrane measurements described 
above.  
Acknowledgements 
This work was supported by a European Research Council (ERC) Grant (261101 
Passmembrane) to UFK. JC acknowledges support from an Internal Graduate Studentship, Trinity 
College, Cambridge, and a Research Studentship from the Cambridge Philosophical Society. SP 
was supported by the Leverhulme Trust through an Early Career Fellowship. TM acknowledges 
support from the Konrad-Adenauer Foundation and the German National Merit Foundation. HB, 
YB and MW are part of the TRANSLOCATION consortium and have received support from the 
Innovative Medicines Joint Undertaking under grant agreement 115525, the European Union’s 
seventh framework program (FP7/2007-2013), and European Federation of Pharmaceutical 
Industries and Associates companies in-kind contribution. We thank Avelino Javer for help with 
the MATLAB scripts and Catalin Chimerel for helpful discussions. 
 
Author Contributions 
JC and HB contributed equally to this work. JC, HB, SP, TM and YB performed the experiments. 
JC, HB, SP, MW and UFK planned the project. JC, HB, SP, MW and UFK wrote the paper.  
All data accompanying this publication are directly available within the publication. 
Financial Interests 
The authors declare no competing financial interests. 
References 
1. Allen, H. K., et al. Call of the wild: antibiotic resistance genes in natural environments. Nat. 
Revs. Microbiol.8, 251-259 (2010). 
2. Cantas, L., et al. A brief multi-disciplinary review on antimicrobial resistance in medicine 
and its linkage to the global environmental microbiota. Frontiers in Microbiol.4, 1-14 
(2013). 
3. McKenna, M. The Last Resort. Nature, 499, 394-396 (2013). 
4. Davies, J. & Davies, D. Origins and Evolution of Antibiotic Resistance. Microbiol. and Mol. 
Biol. Revs.74, 417-433 (2010). 
5. Ling, L. L., et al. A new antibiotic kills pathogens without detectable resistance. Nature, 
517, 455-459 (2015). 
6. Delcour, A. H. Outer Membrane Permeability and Antibiotic Resistance. Biochim. Biophys. 
Acta, 1794 (5), 808-816 (2009). 
7. Pagès, J-M., James, C. E. & Winterhalter, M. The porin and the permeating antibiotic: a 
selective diffusion barrier in Gram-negative bacteria. Nat. Revs. Microbiol.,6, 893-903 
(2008). 
8. Redgrave, L. S., Sutton, S. B., Webber, M. A. & Piddock, L. J. V. Fluoroquinolone 
resistance: mechanisms, impact on bacteria, and role in evolutionary success. Trends in 
Microbiol., 22(8), 438-445 (2014).  
9. Chevalier, J., Malléa, M. & Pagès, J-M. Comparative aspects of the diffusion of 
norfloxacin, cefepime and spermine through the F porin channel of Enterobacter cloacae. 
Biochem. J., 348, 223-227 (2000).  
10. Hirai, K., et al. Isolation and Characterization of Norfloxacin-Resistant Mutants of 
Escherichia coli K-12. Antimicrob. Agents Chemother.,30, 248-253 (1986). 
11. Cohen, S. P., McMurry, L. M., Hooper, D. C., Wolfson, J. S. & Levy, S. B. Cross-
Resistance to Fluoroquinolones in Multiple Antibiotic-Resistant (Mar) Escherichia coli 
Selected by Tetracycline or Chloramphenicol: Decreased Drug Accumulation Associated 
with Membrane Changes in Addition to OmpF Reduction. Antimicrob. Agents Chemother., 
33, 1318-1325 (1989). 
12. Kishii, R. & Takei, M. Relationship between the expression of ompF and quinolone 
resistance in Escherichia coli. J. Infect. Chemother.,15, 361-366 (2009). 
13. Stavenger R. A & Winterhalter M. TRANSLOCATION Project: How to Get Good Drugs 
into Bad Bugs. Sci. Transl. Med., 6, 228ed7 (2014). 
14. Hooper, D. C. Mechanisms of Action of Antimicrobials: Focus on Fluoroquinolones. Clin. 
Infect. Dis., 32 (Suppl. 1), S9-S15 (2001). 
15. Zeiler, H. J. Evaluation of the in vitro bactericidal action of ciprofloxacin on cells of 
Escherichia coli in the logarithmic and stationary phases of growth. Antimicrob. Agents 
Chemother.,28, 524–527(1985). 
16. Hooper, D. C., Wolfson, J. S., Souza, K. S., Ng, E. Y., McHugh, G. L. & Swartz, M. N. 
Mechanisms of quinolone resistance in Escherichia coli: characterization of nfxB and cfxB, 
two mutant resistance loci decreasing norfloxacin accumulation. Antimicrob. Agents 
Chemother.33, 283–290(1989). 
17. Smith, J. T. & Ratcliffe, N. T. Effect of pH value and magnesium on the antibacterial activity 
of quinolone preparations. Infection,14 Suppl 1, S31–35 (1986). 
18. Nikaido, H. & Thanassi, D. G. Penetration of Lipophilic Agents with Multiple Protonation 
Sites into Bacterial Cells: Tetracyclines and Fluoroquinolones as Examples. Antimicrob. 
Agents Chemother., 37, 1393-1399 (1993). 
19. Piddock, L. J. V., Jin, Y.-F., Ricci, V. & Asuquo, A. E. Quinolone accumulation by 
Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia coli. J. Antimicrob. 
Chemother., 43, 61-70 (1999). 
20. Thomas, A. D. & Booth, I. R. The regulation of expression of the porin gene ompC by acid 
pH. J. Gen. Microbiol., 138, 1829-1835 (1992). 
21. Sen, K., Hellman, J. & Nikaido, H. Porin Channels in Intact Cells of Escherichia coli Are 
Not Affected by Donnan Potentials Across the Outer Membrane. J. Biol. Chem., 263 (3), 
1182-1187 (1988).  
22. Kennedy, E. P. Osmotic regulation and the biosynthesis of membrane-derived 
oligosaccharides in Escherichia coli. Proc. Nat. Acad. Sci. USA, 79, 1092-1095 (1982). 
23. Mortimer P. G. & Piddock, L. J. A comparison of methods used for measuring the  
accumulation of quinolones by Enterobacteriaceae, Pseudomonas aeruginosa and 
Staphylococcus aureus. J. Antimicrob. Chemother. 38, 639-653 (1991). 
24. Kaščáková, S., Maigre, L., Chevalier, J., Réfrégiers, M. & Pagès, J. M. Antibiotic transport 
in resistant bacteria: Synchrotron UV fluorescence microscopy to determine antibiotic 
accumulation with single cell resolution. PLOS ONE 7, e38624 (2012). 
25. Cama, J., Chimerel, C., Pagliara, S., Javer, A. & Keyser, U. F. A label-free microfluidic 
assay to quantitatively study antibiotic diffusion through lipid membranes. Lab Chip, 14, 
2303-2308 (2014). 
26. Angelova, M. I. & Dimitrov, D. S. Liposome Electroformation. Faraday Discuss. Chem. 
Soc., 81, 303-311 (1986). 
27. Mahendran, K. R., et al. Molecular Basis of Enrofloxacin Translocation through OmpF, an 
Outer Membrane Channel of Escherichia coli – When Binding Does Not Imply 
Translocation. J. Phys. Chem. B,114, 5170–5179 (2010). 
28. Benz, R., Schmid, A. & Vos-Scheperkeuter, G. H. Mechanism of sugar transport through 
the sugar-specific LamB channel of Escherichia coli outer membrane. J. Membr. 
Biol.100(1), 21–29(1987). 
29. Schwarz, G., Danelon, C. & Winterhalter, M. On Translocation Through a Membrane 
Channel via an Internal Binding Site: Kinetics and Voltage Dependence. Biophys. J., 84, 
2990-2998 (2003).  
30. Bezrukov, S. M., Berezhkovskii, A. M. & Szabo, A. Diffusion model of solute dynamics in 
a membrane channel: Mapping onto the two-site model and optimizing the flux. J. Chem. 
Phys., 127, 115101 (2007).  
31. Wilks, J. C. & Slonczewski, J. L. pH of the cytoplasm and periplasm of Escherichia coli: 
rapid measurement by green fluorescent protein fluorimetry. J. Bacteriol.189, 5601–5607 
(2007). 
32. Nikaido, H. & Rosenberg, E. Y. Porin channels in Escherichia coli: studies with liposomes 
reconstituted from purified proteins. J. Bacteriol.153, 241–252 (1983). 
33. Yoshimura, F. & Nikaido, H. Diffusion of beta-lactam antibiotics through the porin channels 
of Escherichia coli K-12. Antimicrob. Agents Chemother.27, 84–92(1985). 
34. Karamdad, K., Law, R. V., Seddon, J. M., Brooks, N. J. & Ces, O. Preparation and 
mechanical characterisation of giant unilamellar vesicles by a microfluidic method. Lab 
Chip, 15, 557-562 (2015). 
35. Delcour, A. H. Function and modulation of bacterial porins: insights from 
electrophysiology. FEMS Microbiol. Lett.,151, 115-123 (1997).  
36. Delcour, A. H., Martinac, B., Adler, J. & Kung, C. Modified reconstitution method used in 
patch-clamp studies of Escherichia coli ion channels. Biophys. J., 56, 632-636 (1989). 
37. Buechner, M., Delcour, A. H., Martinac, B., Adler, J. & Kung, C. Ion channel activities in 
the Escherichia coli outer membrane. Biochim. Biophys. Acta, 1024, 111-121 (1990). 
38. Nestorovich, E. M., Danelon, C., Winterhalter, M. & Bezrukov, S. M. Designed to 
penetrate: Time-resolved interaction of single antibiotic molecules with bacterial pores. 
Proc. Nat. Acad. Sci. USA, 99, 9789-9794 (2002). 
39. Stuurman, N., Amdodaj, N. & Vale, R. Manager: Open Source Software for Light 
Microscope Imaging. Microscopy Today, 15, 42-43 (2007).  
40. Qin, D., Xia, Y. & Whitesides, G. M. Soft lithography for micro- and nanoscale patterning. 
Nat. Protocols, 5, 491-502 (2010). 
41. Kreir, M., Farre, C., Beckler, M., George, M. & Fertig, N. Rapid screening of membrane 
protein activity: electrophysiological analysis of OmpF reconstituted in proteoliposomes. 
Lab Chip, 8, 587-595 (2008). 
42. Singh, P. R., Ceccarelli, M., Lovelle, M., Winterhalter, M. & Mahendran, K. R. Antibiotic 
Permeation across the OmpF Channel: Modulation of the Affinity Site in the Presence of 
Magnesium. J. Phys. Chem. B, 116, 4433-4438 (2012). 
43. Montal, M. & Mueller, P. Formation of Bimolecular Membranes from Lipid Monolayers and 
a Study of their Electrical Properties. Proc. Nat. Acad. Sci. USA, 69, 3561-3566 (1972). 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1: Antibiotic association (kon) and dissociation (koff) rate constants obtained by single 
channel measurements for OmpF at pH 5 and pH 7. Electrolyte conditions: 1 M KCl, 5 mM PO4 
(pH 7)/acetate (pH 5). 
kon= ( {No. of events/sec}/ 3*[c] ), koff= (1/residence time) 
J= 
kon
cis .ccis .kon
trans 
(kon
cis +kon
trans )
; Δc=1 mM: valid under koff >>> kon . c 
 
 
Antibiotics 
k
on
cis
  (10
3
 ) {1/(s*M)} k
on
trans
(10
3
 ) {1/(s*M)} k
off
total
 1/(s) 
 
J (molecules/s) 
 
Norfloxacin 
 
-50mV 
 
+50mV 
  
Δc=1 mM 
 
pH 7 
 
13 ± 5 
 
1.3 
 
1561 ± 120 
 
 
1 
 
pH 5 
 
11 ± 3 
 
10 
 
25000 
 
 
5 ± 1 
 
 
 
-25mV 
 
+25mV 
 
  
 
 
pH 7 
 
9 ± 2.5 
 
1 
 
1150 ± 60 
 
 
0.9 
 
pH 5 
 
3 ± 1 
 
5 ± 2 
 
27000 
 
 
1.8 ± 0.7 
     
  
0 mV (Optofluidics) 
   
 
pH 7 
 
 
 
 
 
 
 
10 ± 7 
 
pH 5 
 
 
 
 
 
  
 
14 ± 9 
Errors are standard deviations.  
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